ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Life Molecular Imaging Limited

Life Molecular Imaging Limited is an active company incorporated on 8 July 2003 with the registered office located in Fareham, Hampshire. Life Molecular Imaging Limited was registered 22 years ago.
Status
Active
Active since incorporation
Company No
04824675
Private limited company
Age
22 years
Incorporated 8 July 2003
Size
Large
Turnover is over £54M
Balance sheet is over £27M
Confirmation
Submitted
Dated 27 June 2025 (2 months ago)
Next confirmation dated 27 June 2026
Due by 11 July 2026 (10 months remaining)
Last change occurred 2 months ago
Accounts
Submitted
For period 1 Oct30 Sep 2024 (1 year)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (1 year remaining)
Contact
Address
25 Barnes Wallis Road,
Fareham
Hampshire
PO15 5TT
United Kingdom
Address changed on 27 Jun 2024 (1 year 2 months ago)
Previous address was
Telephone
02392415401
Email
Available in Endole App
People
Officers
8
Shareholders
1
Controllers (PSC)
1
Director • None • German • Lives in Germany • Born in Apr 1962
Director • Group Chief Financial Officer • South African • Lives in South Africa • Born in Aug 1971
Director • General Counsel, Chief Administrative Officer • American • Lives in United States • Born in Dec 1976
Director • British • Lives in UK • Born in Dec 1968
Director • Group Chief Executive • South African • Lives in South Africa • Born in Sep 1965
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
No mutual companies found
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
30 Sep 2024
For period 30 Sep30 Sep 2024
Traded for 12 months
Cash in Bank
£24.9M
Increased by £22.68M (+1018%)
Turnover
£67.18M
Increased by £45.97M (+217%)
Employees
10
Increased by 2 (+25%)
Total Assets
£132.25M
Increased by £17.7M (+15%)
Total Liabilities
-£71.3M
Increased by £6.6M (+10%)
Net Assets
£60.96M
Increased by £11.1M (+22%)
Debt Ratio (%)
54%
Decreased by 2.57% (-5%)
Latest Activity
Michel Pieter Jongens Resigned
26 Days Ago on 11 Aug 2025
Ludger Maria Theodor Dinkelborg Resigned
1 Month Ago on 25 Jul 2025
Nico Francois Beukman Resigned
1 Month Ago on 25 Jul 2025
Mr Daniel Niedzwiecki Appointed
1 Month Ago on 21 Jul 2025
Mr Brian Markison Appointed
1 Month Ago on 21 Jul 2025
Mr Robert J Marshall, Jr Appointed
1 Month Ago on 21 Jul 2025
Peter Gerard Wharton Hood Resigned
1 Month Ago on 21 Jul 2025
Lantheus Radiopharmaceuticals Uk Limited (PSC) Appointed
1 Month Ago on 21 Jul 2025
Petrus Phillippus Van Der Westhuizen Resigned
1 Month Ago on 21 Jul 2025
Life Medical Group Limited (PSC) Resigned
1 Month Ago on 21 Jul 2025
Get Credit Report
Discover Life Molecular Imaging Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Termination of appointment of Michel Pieter Jongens as a director on 11 August 2025
Submitted on 12 Aug 2025
Current accounting period extended from 30 September 2025 to 31 December 2025
Submitted on 30 Jul 2025
Appointment of Mr Robert J Marshall, Jr as a director on 21 July 2025
Submitted on 30 Jul 2025
Cessation of Life Medical Group Limited as a person with significant control on 21 July 2025
Submitted on 30 Jul 2025
Appointment of Mr Brian Markison as a director on 21 July 2025
Submitted on 30 Jul 2025
Termination of appointment of Petrus Phillippus Van Der Westhuizen as a director on 21 July 2025
Submitted on 30 Jul 2025
Termination of appointment of Nico Francois Beukman as a director on 25 July 2025
Submitted on 30 Jul 2025
Appointment of Mr Daniel Niedzwiecki as a director on 21 July 2025
Submitted on 30 Jul 2025
Notification of Lantheus Radiopharmaceuticals Uk Limited as a person with significant control on 21 July 2025
Submitted on 30 Jul 2025
Termination of appointment of Peter Gerard Wharton Hood as a director on 21 July 2025
Submitted on 30 Jul 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year